Literature DB >> 18265302

Overview of the HIV-1 Lentiviral Vector System.

Ali Ramezani1, Robert G Hawley.   

Abstract

Replication-defective oncoretroviral vectors have been the most widely used vehicles for gene-transfer studies because of their capacity to efficiently introduce and stably express transgenes in mammalian cells. A limitation of oncoretroviral vectors is that cell division is required for proviral integration into the host genome. By comparison, lentiviruses such as human immunodeficiency virus type 1 (HIV-1) have evolved a nuclear-import machinery that allows them to infect nondividing as well as dividing cells. This unique property has led to the development of lentiviral vectors for gene delivery to a variety of nondividing or slowly dividing cells including neurons and glial cells of the central nervous system and others. This unit is intended to provide an overview of HIV-1 molecular biology and an introduction to successive generations of HIV-1-based lentiviral vectors.

Entities:  

Mesh:

Year:  2002        PMID: 18265302     DOI: 10.1002/0471142727.mb1621s60

Source DB:  PubMed          Journal:  Curr Protoc Mol Biol        ISSN: 1934-3647


  13 in total

Review 1.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

2.  YB-1 stabilizes HIV-1 genomic RNA and enhances viral production.

Authors:  Xin Mu; Wei Li; Xinlu Wang; Guangxia Gao
Journal:  Protein Cell       Date:  2013-04-15       Impact factor: 14.870

3.  Lentiviral fluorescent protein expression vectors for biotinylation proteomics.

Authors:  Irene Riz; Teresa S Hawley; Robert G Hawley
Journal:  Methods Mol Biol       Date:  2011

4.  Strategies to insulate lentiviral vector-expressed transgenes.

Authors:  Ali Ramezani; Robert G Hawley
Journal:  Methods Mol Biol       Date:  2010

Review 5.  Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges.

Authors:  Sumit Ghosh; Alex M Brown; Chris Jenkins; Katie Campbell
Journal:  Appl Biosaf       Date:  2020-03-01

6.  Virally mediated gene manipulation in the adult CNS.

Authors:  Efrat Edry; Raphael Lamprecht; Shlomo Wagner; Kobi Rosenblum
Journal:  Front Mol Neurosci       Date:  2011-12-26       Impact factor: 5.639

7.  Generation of a genome scale lentiviral vector library for EF1α promoter-driven expression of human ORFs and identification of human genes affecting viral titer.

Authors:  Dubravka Škalamera; Mareike Dahmer; Amy S Purdon; Benjamin M Wilson; Max V Ranall; Antje Blumenthal; Brian Gabrielli; Thomas J Gonda
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

8.  Atypical chemokine receptor D6 inhibits human non-small cell lung cancer growth by sequestration of chemokines.

Authors:  Feng Ying Wu; Jiang Fan; Liang Tang; Yin Min Zhao; Cai Cun Zhou
Journal:  Oncol Lett       Date:  2013-05-21       Impact factor: 2.967

Review 9.  Risks Associated With Lentiviral Vector Exposures and Prevention Strategies.

Authors:  Ryan Schlimgen; John Howard; Dawn Wooley; Maureen Thompson; Lindsey R Baden; Otto O Yang; David C Christiani; Gustavo Mostoslavsky; David V Diamond; Elizabeth Gilman Duane; Karen Byers; Thomas Winters; Jeffrey A Gelfand; Gary Fujimoto; T Warner Hudson; Jatin M Vyas
Journal:  J Occup Environ Med       Date:  2016-12       Impact factor: 2.162

Review 10.  Production of lentiviral vectors.

Authors:  Otto-Wilhelm Merten; Matthias Hebben; Chiara Bovolenta
Journal:  Mol Ther Methods Clin Dev       Date:  2016-04-13       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.